|
2002 Publications Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 200 2; 106(23):2941-2945.
Chavers BM, Li S, Collins AJ, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 2002; 62(2):648-653. [Also listed under Nephrology]
Foley RN , Herzog CA , Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int. 2002; 62(5):1784-1790. [Also listed under Nephrology]
Goldsmith SR. Congestive heart failure: potential role of arginine vasopressin antagonists in the therapy of heart failure. Congest Heart Fail. 2002; 8(5):251-256.
Goldsmith SR. Vasopressin antagonists in CHF: ready for clinical trials? Cardiovasc Res. 2002;54 (1):13-15.
Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002; 106(17):2207-2211. [Also listed under Nephrology]
Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified? Circulation. 2002; 105(11):1336-1341. [Also listed under Nephrology]
Herzog CA. Dismal long-term survival of dialysis patients after acute myocardial infarction: Can we alter the outcome? Nephrol Dial Transplant. 2002; 17(1):7-10.
Shah BR, Velazquez E, Shaw LK, Bart B, O’Connor C, Wagner GS. Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts. Am Heart J. 2002; 143(1):111-117.
Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002; 137(7):563-570.
2001 Publications
Alpert JS,
Budaj AJ, Gurfinkel EP, Henry TD. Issues in antithrombin therapy
for UA/NSTEMI. Eur Heart J. 2001;3:J15-J23. Asinger
RW, Henry TD, Herzog CA, Paulsen PR, Kane RL. Clinical outcomes of
PTCA in chronic renal failure: a case-control study for comorbid features
and evaluation of dialysis dependence. J Invasive Cardiol. 2001;13(1):21-28.
Collins
AJ, Li S, Ma JZ, Herzog C. Cardiovascular disease in end-stage
renal disease patients. Am J Kidney Dis. 2001;38(4 suppl. 1):S26-S29.
(Also listed under Nephrology) Fuster V, Ryden
LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management
of patients with atrial fibrillation. A report of the American College
of Cardiology/American Heart Association Task Force on Practice Guidelines
and the European Society of Cardiology Committee for Practice Guidelines
and Policy Conferences (committee to develop guidelines for the management
of patients with atrial fibrillation) developed in collaboration with
the North American Society of Pacing and Electrophysiology. Eur Heart
J. 2001; 22(20):1852-1923. Fuster V, Ryden
LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management
of patients with atrial fibrillation: executive summary. A report of the
American College of Cardiology/American Heart Association Task Force on
Practice Guidelines and the European Society of Cardiology Committee for
Practice Guidelines and Policy Conferences (committee to develop guidelines
for the management of patients with atrial fibrillation) developed in
collaboration with the North American Society of Pacing and Electrophysiology.
J Am Coll Cardiol. 2001;38(4):1231-1266. Fuster V, Ryden
LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management
of patients with atrial fibrillation: executive summary. A report of the
American College of Cardiology/American Heart Association Task Force on
Practice Guidelines and the European Society of Cardiology Committee for
Practice Guidelines and Policy Conferences (committee to develop guidelines
for the management of patients with atrial fibrillation) developed in
collaboration with the North American Society of Pacing and Electrophysiology.
Circulation. 2001;104(17):2118-2150. Henry TD,
Rocha-Singh K, Isner JM, et al. Intracoronary administration of recombinant
human vascular endothelial growth factor to patients with coronary artery
disease. Am Heart J. 2001;142(5):872-880. Henry TD,
Satran D, Knox LL, Iacarella CL, Laxson DD, Antman EM. Are activated
clotting times helpful in the management of anticoagulation with subcutaneous
low-molecular-weight heparin? Am Heart J. 2001;142(4):590-593.
(Also listed under Internal Medicine Residency Program) Herzog CA,
Apple FS. Cardiac biomarkers in the new millennium. Semin Dial.
2001; 14(5):322-323. Klein AL, Grimm
RA, Murray RD, Apperson-Hansen C, Asinger RW, et al. Use of transesophageal
echocardiography to guide cardioversion in patients with atrial fibrillation.
N Engl J Med. 2001;344(19):1411-1420. Llevadot J,
Giugliano RP, Antman EM, Wilcox RG, Gurfinkel EP, Henry T, et al.
Availability of on-site catheterization and clinical outcomes in patients
receiving fibrinolysis for ST-elevation myocardial infarction. Eur
Heart J. 2001;22(22):2104-2115. Stokman PJ,
Nandra CS, Asinger RW. Left ventricular thrombus. Curr Treat Options
Cardiovasc Med. 2001;3(6):515-521. Whellan DJ,
Shaw LK, Bart BA, Kraus WE, Califf RM, O'Connor CM. Cardiac rehabilitation
and survival in patients with left ventricular systolic dysfunction. Am
Heart J. 2001;142(1):160-166. Wilke NM, Zenovich AG, Jerosch-Herold M, Henry TD. Cardiac magnetic resonance imaging for the assessment of myocardial angiogenesis. Curr Interv Cardiol Rep. 2001; 3(3):205-212.
|
